Titre
Substances injected at the Sydney supervised injecting facility: A chemical analysis of used injecting equipment and comparison with self-reported drug type.
Type
article
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Auteur(s)
Lefrancois, E.
Auteure/Auteur
Belackova, V.
Auteure/Auteur
Silins, E.
Auteure/Auteur
Latimer, J.
Auteure/Auteur
Jauncey, M.
Auteure/Auteur
Shimmon, R.
Auteure/Auteur
Mozaner Bordin, D.
Auteure/Auteur
Augsburger, M.
Auteure/Auteur
Esseiva, P.
Auteure/Auteur
Roux, C.
Auteure/Auteur
Morelato, M.
Auteure/Auteur
Liens vers les personnes
Liens vers les unités
ISSN
1879-0046
Statut éditorial
Publié
Date de publication
2020-04-01
Volume
209
Première page
107909
Peer-reviewed
Oui
Langue
anglais
Notes
Publication types: Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Publication Status: ppublish
Résumé
Providing information about substances injected can reduce the negative impact of illicit drug consumption and support people who inject drugs to make informed decisions. In Australia, information about drugs injected relies largely on periodic self-report surveys. For the first time, the analysis of the residual content of used injecting equipment was conducted in a supervised injecting facility (SIF) located in Sydney, Australia. The aim was to gain a better understanding of the substances injected by clients through: (1) chemical analyses of the content of used syringes; (2) comparison of these results with clients' self-reported drug use; and (3) assessing the usefulness of analysing other injecting equipment to detect substances used. During one week in February 2019, syringes and other injecting equipment were collected at the Sydney SIF. Their residual content was analysed by gas-chromatography/mass-spectrometry. Heroin was the most commonly detected substance (present in 51% of syringes), followed by methamphetamine (22%) and oxycodone (10%). In addition to the main psychoactive substance, cutting agents reported in the literature were also detected in used syringes. The main psychoactive substance identified by laboratory analysis reliably corresponded with users' self-reported drug type. Analytical confirmation of substances injected allows for the provision of better targeted harm reduction messaging based on timely and objective data. The approach used is amenable to clients and feasible in the Australian SIF context. Upscaling and wider implementation could be done through Needle and Syringe Programs, and would support the early detection of harmful substances entering drug markets and better inform harm reduction strategies.
Sujets
PID Serval
serval:BIB_BD684EDE54A6
PMID
Open Access
Oui
Date de création
2020-02-26T10:15:22.705Z
Date de création dans IRIS
2025-05-20T21:44:03Z
Fichier(s)![Vignette d'image]()
En cours de chargement...
Nom
32145660.pdf
Version du manuscrit
published
Licence
https://creativecommons.org/licenses/by-nc-nd/4.0
Taille
1.22 MB
Format
Adobe PDF
PID Serval
serval:BIB_BD684EDE54A6.P001
URN
urn:nbn:ch:serval-BIB_BD684EDE54A60
Somme de contrôle
(MD5):5a7319af312bd57136ba65170c5dd655